DrugPatentWatch Database Preview
Actavis Llc Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for ACTAVIS LLC, and what generic and branded alternatives to ACTAVIS LLC drugs are available?
ACTAVIS LLC has ten approved drugs.
There are two tentative approvals on ACTAVIS LLC drugs.
Summary for Actavis Llc
| US Patents: | 0 |
| Tradenames: | 9 |
| Ingredients: | 9 |
| NDAs: | 10 |
| Patent Litigation for Actavis Llc: | See patent lawsuits for Actavis Llc |
| PTAB Cases with Actavis Llc as petitioner: | See PTAB cases with Actavis Llc as petitioner |
Drugs and US Patents for Actavis Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Llc | DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 203551-004 | Sep 21, 2015 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Actavis Llc | LEVOLEUCOVORIN CALCIUM | levoleucovorin calcium | POWDER;INTRAVENOUS | 206516-001 | Feb 13, 2017 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Actavis Llc | BUSULFAN | busulfan | INJECTABLE;INJECTION | 205139-001 | Dec 8, 2017 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Actavis Llc | MELPHALAN HYDROCHLORIDE | melphalan hydrochloride | INJECTABLE;INJECTION | 206018-001 | Dec 19, 2016 | AP | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
